Дункан Кармайкл - Молодость навсегда. Как замедлить процессы старения и сохранить здоровье
- Название:Молодость навсегда. Как замедлить процессы старения и сохранить здоровье
- Автор:
- Жанр:
- Издательство:неизвестно
- Год:2018
- ISBN:978-5-389-18963-8
- Рейтинг:
- Избранное:Добавить в избранное
-
Отзывы:
-
Ваша оценка:
Дункан Кармайкл - Молодость навсегда. Как замедлить процессы старения и сохранить здоровье краткое содержание
«Современный мир дает возможность как поддерживать здоровье в пре-красном состоянии, так и еще в молодом возрасте „заработать“ тяжелые хронические заболевания. Очевидно, что в большинстве случаев наше здоровье в наших руках. Вопрос в том, как определить, что помогает, а что вредит? Все так быстро меняется во всех областях медицины, что вчерашнее лекарство завтра может быть признано вредным (и это не учитывая аферистов в белых халатах, пытающихся впарить шарлатанские средства от всех болезней). Поиск надежной информации в эпоху интернета становится нелегкой задачей. Моя цель – составить для вас полезную дорожную карту». (Дункан Кармайкл)
В формате PDF A4 сохранён издательский дизайн.
Молодость навсегда. Как замедлить процессы старения и сохранить здоровье - читать онлайн бесплатно ознакомительный отрывок
Интервал:
Закладка:
452
Hersh, A. L. et al. ‘National use of postmenopausal hormone therapy: annual trends and response to recent evidence.’ JAMA (2004): 291 (1): 47–53d.
453
Sarrel, P. M. et al. ‘The mortality toll of oestrogen avoidance: an analysis of excessive deaths among hysterectomized women aged 50 to 59 years.’ Am J Public Health (2013): 103: 1583–1588.
454
Barrett-Connor, E. ‘Sex dif erences in coronary heart disease. Why are women so superior?’ The 1995 Ancel Keys Lecture. Circulation (1997): 95: 252–264.
455
Wellons, M. ‘Early menopause associated with increased risk of heart disease, stroke.’ John Hopkins Medicine (2012).
456
Campos, H. et al. ‘Effect of oestrogen on very low-dose density lipoprotein and low density lipoprotein subclass metabolism in postmenopausal women.’ J Clin Endocrinol Metab (1997): 82 (12): 3955–3963.
457
Mendelsohn, M. E. and Karas, R. H. ‘The protective effects of oestrogen on the cardiovascular system.’ N Engl J Med (1990): 340: 1111–1801.
458
Barrett-Connor, E. ‘Sex dif erences in coronary heart disease. Why are women so superior? The 1995 Ancel keys lecture.’ Circulation (1997): 95: 252–264.
459
Grodstein, F. et al. ‘Postmenopausal estrogen and progestin use and the risk of cardiovascular disease.’ N Engl J Med (1996): 335 (7): 453–461.
460
Blakely, J. A. ‘The Heart and Estrogen/Progestin Replacement Study Revisited. Hormone Replacement Therapy Produced Net Harm, Consistent With the Observational Data.’ JAMA (2000): 160: 2897–2900.
461
‘Hormone Replacement Study A Shock to the Medical System’, The New York Times (10 July 2002). URL: http://www.nytimes.com/2002/07/10/us/hormone-replacement-study-a-shock-to-the-medical-system.html?pagewanted=all.
462
Grodstein, F. et al. ‘Postmenopausal hormone therapy and mortality.’ N Engl J Med (1997): 336: 1769–1776.
463
Rossouw, E. et al. ‘Lessons learned from the Women’s Health Initiative trials of meno-pausal hormone therapy.’ Obstet Gynecol (2003): 121: 172–176. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC 3547645/.
464
Anderson, G. L. et al. ‘Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial.’ JAMA (2004): 291: 1701–1712.
465
Rossouw, J. et al. ‘Writing group for the Women’s Health Initiative randomized controlled trial.’ JAMA (2002): 288: 321–333.
466
http://www.icis.com/resources/news/2002/07/17/177264/wyeth-shares-fall-11-to-new-low-on-hormone-drug-fears/.
467
Sarrel, P. M. et al. ‘The mortality toll of oestrogen avoidance: an analysis of excessive deaths among hysterectomized women aged 50 to 59 years.’ Am J Public Health(2013): 103: 1583–1588.
468
Schierbeck, L. L. et al. ‘Effect of hormone replacement therapy on cardiovascular events in recently post-menopausal women: randomised trial’. BMJ (2012): 345: e6409.
469
Sarrel, P. M. et al. ‘The mortality toll of oestrogen avoidance: an analysis of excessive deaths among hysterectomized women aged 50 to 59 years.’ Am J Public Health (2013): 103: 1583–1588.
470
Renoux, C. et al. ‘Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study.’ BMJ (2010): 340: c2519.
471
Rossouw, J. et al. ‘Writing group for the Women’s Health Initiative randomized controlled trial.’ JAMA (2002): 288: 321–333.
472
Schierbeck, L. L. et al. ‘Effect of hormone replacement therapy on cardiovascular events in recently post-menopausal women: randomised trial’. BMJ (2012): 345: e6409.
473
Fournier, A. et al. ‘Risks of endometrial cancer associated with different hormone replace-ment therapies in the E 3N Cohort, 1992–2008.’ Am J Epidemiol Advance Access (2014): 10: 1093.
474
‘The effects of estrogen or estrogen/progestin regimens on heart attack risk factors in post menopausal women. The Postmenopausal oestrogen Progesterone trial (PEPI trial).’ JAMA (1995): 273: 199–208. https://www.ncbi.nlm.nih.gov/pubmed/7807658. Moyer, D. L. et al. ‘Micronized progesterone regulation of the endometrial glandular cycling pool.’ Int J Gynecol Pathol (2001): 20: 374–379.
475
Fournier, A. et al. ‘Unequal risks for breast cancer associated with different hormonal replacement therapies: results from the E 3N cohort study.’ Breast Cancer Res Treat (2008): 107: 103–111.
476
Asi, N. et al. ‘Progesterone vs synthetic progestins and the risk of breast cancer: a systematic review and meta-analysis.’ Syst Rev (2016): 5: 121.
477
‘The effects of estrogen or estrogen/progestin regimens on heart attack risk factors in post menopausal women. The Postmenopausal oestrogen Progesterone trial (PEPI trial).’ JAMA (1995): 273: 199–208. https://www.ncbi.nlm.nih.gov/pubmed/7807658.
478
Diep, C. H. et al. ‘Progesterone action in breast, uterine, and ovarian cancers.’ J Mol Endocrinol (2015): 54: R 31–R 53.
479
‘Cancer incidence for common cancers.’ Cancer Research UK. http://www.cancerresearchuk.org/health-professional/cancer-statistics/incidence/common-cancers-compared#heading-Two.
480
Rinninger, F. et al. ‘Lipoprotein lipase mediates an increase in the selective uptake of high density lipoprotein-associated cholesteryl esters by hepatic cells in culture.’ J Lipid Res (1998): 39 (7): 1335–1348.
481
Price, T. M. et al. ‘Oestrogen regulation of adipose tissue lipoprotein lipase – possible mechanism of body fat distribution.’ Am J Obstet Gynecol (1998): 178: 101–107.
482
Sumino, H. et al. ‘Effects of hormone replacement therapy on weight, abdominal fat distribution and lipid levels in Japanese postmenopausal women.’ Int J Obes (2003): 1044–1051.
483
Jensen, L. B. et al. ‘Hormone replacement therapy dissociates fat mass and bone mass and tends to reduce weight gain in early menopausal women: A randomized prevention study.’ J Bone Miner Res (2003): Vol. 18: 333–342.
484
Sadur, C. N. et al. ‘Insulin stimulation of adipose tissue lipoprotein lipase. Use of the euglycaemic clamp technique.’ J Clin Invest (1982): 69: 1119–1125.
485
Howard, B. V. et al. ‘Insulin resistance and weight gain in post-menopausal women of diverse ethnic groups.’ Int J Obes Relat Metab Disord (2004): 28: 1039–1047.
486
Maybin, J. A. et al. ‘Menstrual physiology: implications for endometrial pathology and beyond.’ Human Reprod (2015): 21: 748–761.
487
Maybin, J. A. et al. ‘Medical management of heavy menstrual bleeding.’ Women’s Health (Long) (2016): 12: 27–34.
488
Smith, S. S. et al. ‘Progesterone alters GABA and glutamate responsiveness: a possible mechanism for its anxiolytic action.’ Brain Res (1987): 400: 353–359.
489
Wang, M. ‘Neurosteroids and GABA-A Receptor Function.’ Front Endocrin (2011): 2: 44.
490
Luine, V. N. et al. ‘Gonadal hormone regulation of MAO and other enzymes in hypo-thalamic areas.’ Neuroendocrinology (1983): 36 (3): 235–241.
491
Cassidenti, D. L. et al. ‘Effects of sex steroids on skin 5 alpha-reductase activity in vitro.’ Obstet Gynecol (1991): 78: 103–107.
492
Payne, A. H. et al. ‘Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones.’ Endocr Rev (2004): 25 (6): 947–970.
493
Skobelov, E. M., Spivey, W. H. et al. ‘The effect of the menstrual cycle on asthma pre sentations in the emergency department.’ Ann Intern Med (1996): 156: 1837–1840.
494
Hanley, S. P. ‘Asthma variation with menstruation.’ Br J Dis Chest (1981): 75: 306–308.
495
Barr, R. G., Wentowski, C. C. et al, ‘Prospective study of postmenopausal hormone use and newly diagnosed asthma and chronic obstructive pulmonary disease.’ Arch Intern Med (2004): 164 (4): 379–386.
496
Foster, P. S., Goldie, R. G., Paterson, J. W. ‘Effect of steroids on β-adrenoceptor-mediated relaxation of pig bronchus.’ Br J Pharmacol (1983): 78: 441–445.
497
Kos-Kudla, B. et al. ‘Effects of hormone replacement therapy on endocrine and spiro-metric parameters in asthmatic postmenopausal women.’ Gynecol Endocrinol(2001): 15: 304–311.
498
Barr, R. G., Wentowski, C. C. et al, ‘Prospective study of postmenopausal hormone use and newly diagnosed asthma and chronic obstructive pulmonary disease.’ Arch Intern Med (2004): 164 (4): 379–386.
499
Miyaura, H. ‘Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids.’ J Immunol (2002): 168: 1087–1094. Hughes, G. C. ‘Progesterone and autoimmune disease.’ Autoimmun Rev (2012): 11: A502–514.
500
Sammaritano, L. R. ‘Menopause in patients with autoimmune diseases.’ Autoimmun Rev (2012): 11: A430–436.
501
Schulze-Koops, H. ‘The balance of Th1/Th2 cytokines in rheumatoid arthritis.’ Best Pract Res Clin Rheumatol (2001): 15: 677–691.
502
Herrera, A. Y. et al. ‘Stress-induced increases in progesterone and cortisol in naturally cycling women.’ Neurobiol Stress (2016): 3: 96–104.
503
http://www.nih.gov/news-events/news-releases/prior-stress-could-worsen-premenstrual-symptoms-nih-study-finds.
504
Roca, C. A. et al. ‘Differential menstrual cycle regulation of hypothalamic-pituitary-adrenal axis in women with premenstrual syndrome and controls.’ J Clin Endocrinol Metab (2003): 88: 3057–3063.
505
Zimmerman, Y. et al. ‘The effect of combined oral contraception on testosterone in healthy women: a systematic review and meta-analysis.’ Hum Reprod Update (2014): 20: 76–105.
506
Persky, H. et al. ‘Plasma testosterone level and sexual behaviour of couples.’ Arch Sex Behav (1978): 7: 157–173.
507
Goldstat, R. et al. ‘Transdermal testosterone therapy improves well-being, mood and sexual function in premenopausal women.’ Menopause (2003): 10: 390–398.
508
Tun, A., Khan, I. A. ‘Acute myocardial infarction with angiographically normal coro-nary arteries.’ Heart Lung (2000): 29: 348–350. Levit, R. D. et al. ‘Cardiovascular disease in young women: a population at risk.’ Cardiol Rev (2011): 19: 60–65.
Читать дальшеИнтервал:
Закладка:
